First Bundibugyo Ebola vaccine trial begins as DRC death toll tops 1,300

Oxford dosed the first volunteer in the world's first vaccine trial for Bundibugyo ebolavirus — a strain with no approved vaccines or treatments — on July 24, 2026. The DRC outbreak has killed 1,309 across 2,973 confirmed cases, a 40 percent rise in five days. A deployable vaccine remains months away.